Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
TechnipFMC
FTI
$30.1B
| $29.3M | 0.06% |
+1,439,693
| New | +$27.2M |
|
452
PBF Energy
PBF
$8.81B
| $29.3M | 0.06% |
882,000
-1,154,000
| -57% | -$36.9M |
|
453
John B. Sanfilippo & Son
JBSS
$1.01B
| $29.2M | 0.06% |
422,300
-39,500
| -9% | -$2.47M |
|
454
Prestige Consumer Healthcare
PBH
$2.43B
| $29.1M | 0.06% |
545,400
+149,300
| +38% | +$7.35M |
|
|
FRAN
455
DELISTED
Francesca's Holdings Corporation
FRAN
| $29.1M | 0.06% |
126,375
+19,375
| +18% | +$4.18M |
|
456
Spok Holdings
SPOK
$230M
| $29M | 0.06% |
1,658,084
-19,616
| -1% | -$334K |
|
457
Clean Harbors
CLH
$16.9B
| $29M | 0.06% |
587,502
+14,612
| +3% | +$640K |
|
|
SKX
458
DELISTED
Skechers
SKX
| $29M | 0.06% |
951,900
+14,000
| +1% | +$421K |
|
459
PetMed Express
PETS
$43.4M
| $28.9M | 0.06% |
1,614,500
-89,820
| -5% | -$1.54M |
|
460
Snap-on
SNA
$20.9B
| $28.9M | 0.05% |
+183,800
| New | +$28.2M |
|
461
Ulta Beauty
ULTA
$22.2B
| $28.8M | 0.05% |
148,800
+142,300
| +2,189% | +$24.8M |
|
|
AF
462
DELISTED
Astoria Financial Corporation
AF
| $28.7M | 0.05% |
1,812,450
+865,944
| +91% | +$13.1M |
|
463
Atmos Energy
ATO
$28.7B
| $28.7M | 0.05% |
386,100
+12,700
| +3% | +$872K |
|
464
Albany International
AIN
$1.82B
| $28.7M | 0.05% |
762,300
+274,000
| +56% | +$9.65M |
|
465
Cenovus Energy
CVE
$56.4B
| $28.6M | 0.05% |
2,201,800
+1,428,700
| +185% | +$17.1M |
|
|
TXNM
466
TXNM Energy Inc
TXNM
$5.91B
| $28.6M | 0.05% |
848,800
+312,700
| +58% | +$10M |
|
|
PGTI
467
DELISTED
PGT, Inc.
PGTI
| $28.6M | 0.05% |
2,904,429
-198,900
| -6% | -$1.94M |
|
468
Pediatrix Medical
MD
$2.14B
| $28.5M | 0.05% |
+441,600
| New | +$29.3M |
|
|
TIF
469
DELISTED
Tiffany & Co.
TIF
| $28.5M | 0.05% |
+388,200
| New | +$26.1M |
|
470
SL Green Realty
SLG
$4.08B
| $28.4M | 0.05% |
303,232
+292,774
| +2,800% | +$26.8M |
|
471
Western Alliance Bancorporation
WAL
$8.92B
| $28.4M | 0.05% |
849,920
+373,600
| +78% | +$11.7M |
|
472
Celanese
CE
$4.86B
| $28.3M | 0.05% |
+432,300
| New | +$26.8M |
|
473
Hawaiian Electric Industries
HE
$2.04B
| $28.2M | 0.05% |
871,400
+18,800
| +2% | +$563K |
|
474
Jazz Pharmaceuticals
JAZZ
$16B
| $28.1M | 0.05% |
215,100
+196,300
| +1,044% | +$24.4M |
|
|
JAH
475
DELISTED
JARDEN CORPORATION
JAH
| $28M | 0.05% |
+474,336
| New | +$25.4M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.